17th May 2010

    New Partner of BORENIUS & Co Expert in Biotechnology

    Patent Attorney Jaana Hämäläinen, Ph.D., has been invited as a partner in BORENIUS & Co Oy Ab. Hämäläinen has worked as an university researcher in Finland, Sweden and the United States in the 1990s, and has been employed at BORENIUS & Co since 2000. Hämäläinen specializes in the patenting of inventions that relate to biotechnology, molecular biology, pharmaceuticals, chemistry and plants. She is also able to provide her customers extensive guidance on issues concerning freedom to operate and civil actions.

    ”Well-timed protection of innovations is of great importance for the research and product development in the field of biotechnology. It is advisable to consult an expert already in the early stages of the R&D process,” says Jaana Hämäläinen.

    Understandably, biotechnological companies and university research groups would like to get their results published in academic publications whenever possible. Hämäläinen points out that publishing and patenting are not mutually exclusive. However, a patent application must, without exception, be filed before publishing. ”In this way, the top results of one’s own research and product development can be transformed into profitable business that also attracts investors,” states Jaana Hämäläinen.

    The entering of Jaana Hämäläinen as a partner of BORENIUS & CO serves to further strengthen the company’s expertise in the field of biotechnology. The other partners of BORENIUS & Co include Pia Hjelt, Silvio Hjelt, Jonna Sahlin, Peter Åkerlund, Karri Leskinen, and Christian Westerholm.

    17.5.2010

    New Partner of BORENIUS & Co Expert in Biotechnology

    Patent Attorney Jaana Hämäläinen, Ph.D., has been invited as a partner in BORENIUS & Co Oy Ab. Hämäläinen has worked as an university researcher in Finland, Sweden and the United States in the 1990s, and has been employed at BORENIUS & Co since 2000. Hämäläinen specializes in the patenting of inventions that relate to biotechnology, molecular biology, pharmaceuticals, chemistry and plants. She is also able to provide her customers extensive guidance on issues concerning freedom to operate and civil actions.

    ”Well-timed protection of innovations is of great importance for the research and product development in the field of biotechnology. It is advisable to consult an expert already in the early stages of the R&D process,” says Jaana Hämäläinen.

    Understandably, biotechnological companies and university research groups would like to get their results published in academic publications whenever possible. Hämäläinen points out that publishing and patenting are not mutually exclusive. However, a patent application must, without exception, be filed before publishing. ”In this way, the top results of one’s own research and product development can be transformed into profitable business that also attracts investors,” states Jaana Hämäläinen.

    The entering of Jaana Hämäläinen as a partner of BORENIUS & CO serves to further strengthen the company’s expertise in the field of biotechnology. The other partners of BORENIUS & Co include Pia Hjelt, Silvio Hjelt, Jonna Sahlin, Peter Åkerlund, Karri Leskinen, and Christian Westerholm.